Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin ...
Corporate history is replete with examples of the ‘third generation curse’, but the Daftary family seem to be bucking that ...
Alkem Laboratories announced the launch of NeuCeno (cenobamate), anti-seizure medication (ASM) for the treatment of ...
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it has signed a non-exclusive license agreement ...
Shilpa Biologicals, an integrated biologics development and manufacturing organisation, announces an exclusive Middle East ...
A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extolled the benefits of the QR barcoding programme ...
Innovation is often measured through rankings, patents and startup success stories. While these are important indicators, ...
For much of the past two decades, global biotech leadership has clustered around a handful of hubs, each anchored by patient ...
A landmark collaborative study led by the University of Sheffield has proposed a new framework bringing 108 rare lysosomal disorders together, potentially enabling more precise diagnosis and helping r ...
The conversation around environmental sustainability in the pharma industry is now expanding beyond the traditional ...
Oncodesign Services and Nexus BioQuest have formed a partnership connecting their respective in vitro and in vivo expertise, ...
Congress 2026, AstraZeneca presented the design of the Phase IIb PRESTO trial, a large study set to evaluate whether AZD6793, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results